Oncology Institute (TOI) Short-term Investments (2022 - 2024)
Historic Short-term Investments for Oncology Institute (TOI) over the last 3 years, with Q2 2024 value amounting to $9.9 million.
- Oncology Institute's Short-term Investments fell 342.05% to $9.9 million in Q2 2024 from the same period last year, while for Jun 2024 it was $9.9 million, marking a year-over-year decrease of 342.05%. This contributed to the annual value of $49.4 million for FY2023, which is 1744.1% down from last year.
- Per Oncology Institute's latest filing, its Short-term Investments stood at $9.9 million for Q2 2024, which was down 342.05% from $29.8 million recorded in Q1 2024.
- Over the past 5 years, Oncology Institute's Short-term Investments peaked at $59.9 million during Q3 2023, and registered a low of $9.9 million during Q2 2024.
- Moreover, its 3-year median value for Short-term Investments was $35.0 million (2023), whereas its average is $36.0 million.
- Its Short-term Investments has fluctuated over the past 5 years, first soared by 10538.18% in 2023, then crashed by 2580.24% in 2024.
- Quarter analysis of 3 years shows Oncology Institute's Short-term Investments stood at $59.8 million in 2022, then dropped by 17.44% to $49.4 million in 2023, then plummeted by 79.87% to $9.9 million in 2024.
- Its last three reported values are $9.9 million in Q2 2024, $29.8 million for Q1 2024, and $49.4 million during Q4 2023.